188 related articles for article (PubMed ID: 31090642)
1. Chronic lung allograft dysfunction: light at the end of the tunnel?
Verleden SE; Vos R; Verleden GM
Curr Opin Organ Transplant; 2019 Jun; 24(3):318-323. PubMed ID: 31090642
[TBL] [Abstract][Full Text] [Related]
2. Chronic Lung Allograft Dysfunction: Evolving Concepts and Therapies.
DerHovanessian A; Wallace WD; Lynch JP; Belperio JA; Weigt SS
Semin Respir Crit Care Med; 2018 Apr; 39(2):155-171. PubMed ID: 29579768
[TBL] [Abstract][Full Text] [Related]
3. Chronic lung allograft dysfunction: evolving practice.
Vos R; Verleden SE; Verleden GM
Curr Opin Organ Transplant; 2015 Oct; 20(5):483-91. PubMed ID: 26262458
[TBL] [Abstract][Full Text] [Related]
4. Validation of a post-transplant chronic lung allograft dysfunction classification system.
Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R
J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
[TBL] [Abstract][Full Text] [Related]
6. The potential of biomarkers of fibrosis in chronic lung allograft dysfunction.
van der Ploeg EA; Melgert BN; Burgess JK; Gan CT
Transplant Rev (Orlando); 2021 Jul; 35(3):100626. PubMed ID: 33992914
[TBL] [Abstract][Full Text] [Related]
7. Chronic lung allograft dysfunction and restrictive allograft syndrome: are phenotypes robust and helpful?
Verleden GM; Godinas L; Vos R; Verleden SE
Curr Opin Organ Transplant; 2022 Jun; 27(3):211-216. PubMed ID: 35649111
[TBL] [Abstract][Full Text] [Related]
8. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
Benden C; Haughton M; Leonard S; Huber LC
J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986
[TBL] [Abstract][Full Text] [Related]
9. Emerging biomarkers in chronic lung allograft dysfunction.
Shtraichman O; Diamond JM
Expert Rev Mol Diagn; 2020 May; 20(5):467-475. PubMed ID: 32133875
[No Abstract] [Full Text] [Related]
10. Update in Chronic Lung Allograft Dysfunction.
Shah RJ; Diamond JM
Clin Chest Med; 2017 Dec; 38(4):677-692. PubMed ID: 29128018
[TBL] [Abstract][Full Text] [Related]
11. Chronic Lung Allograft Dysfunction: A Systematic Review of Mechanisms.
Royer PJ; Olivera-Botello G; Koutsokera A; Aubert JD; Bernasconi E; Tissot A; Pison C; Nicod L; Boissel JP; Magnan A;
Transplantation; 2016 Sep; 100(9):1803-14. PubMed ID: 27257997
[TBL] [Abstract][Full Text] [Related]
12. When tissue is the issue: A histological review of chronic lung allograft dysfunction.
Verleden SE; Von der Thüsen J; Roux A; Brouwers ES; Braubach P; Kuehnel M; Laenger F; Jonigk D
Am J Transplant; 2020 Oct; 20(10):2644-2651. PubMed ID: 32185874
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of chronic lung allograft dysfunction patients with mixed phenotype: A single-center study.
Verleden SE; Von Der Thüsen J; Van Herck A; Weynand B; Verbeken E; Verschakelen J; Dubbeldam A; Vanaudenaerde BM; Vos R; Verleden GM;
Clin Transplant; 2020 Feb; 34(2):e13781. PubMed ID: 31958356
[TBL] [Abstract][Full Text] [Related]
14. Impact of chronic lung allograft dysfunction, especially restrictive allograft syndrome, on the survival after living-donor lobar lung transplantation compared with cadaveric lung transplantation in adults: a single-center experience.
Sugimoto S; Yamamoto H; Kurosaki T; Otani S; Okazaki M; Yamane M; Toyooka S; Oto T
Surg Today; 2019 Aug; 49(8):686-693. PubMed ID: 30790054
[TBL] [Abstract][Full Text] [Related]
15. Restrictive chronic lung allograft dysfunction: Where are we now?
Verleden SE; Ruttens D; Vandermeulen E; Bellon H; Van Raemdonck DE; Dupont LJ; Vanaudenaerde BM; Verleden G; Vos R
J Heart Lung Transplant; 2015 May; 34(5):625-30. PubMed ID: 25577564
[TBL] [Abstract][Full Text] [Related]
16. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
[TBL] [Abstract][Full Text] [Related]
17. The diagnosis and management of chronic lung allograft dysfunction.
Verleden GM; Hendriks JMH; Verleden SE
Curr Opin Pulm Med; 2024 Jul; 30(4):377-381. PubMed ID: 38305383
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive methods for detection of chronic lung allograft dysfunction in lung transplantation.
Tian D; Huang H; Wen HY
Transplant Rev (Orlando); 2020 Jul; 34(3):100547. PubMed ID: 32498976
[TBL] [Abstract][Full Text] [Related]
19. Low-dose computed tomography volumetry for subtyping chronic lung allograft dysfunction.
Saito T; Horie M; Sato M; Nakajima D; Shoushtarizadeh H; Binnie M; Azad S; Hwang DM; Machuca TN; Waddell TK; Singer LG; Cypel M; Liu M; Paul NS; Keshavjee S
J Heart Lung Transplant; 2016 Jan; 35(1):59-66. PubMed ID: 26342441
[TBL] [Abstract][Full Text] [Related]
20. Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival.
Horie M; Salazar P; Saito T; Binnie M; Brock K; Yasufuku K; Azad S; Keshavjee S; Martinu T; Paul N
Clin Transplant; 2018 May; 32(5):e13233. PubMed ID: 29637624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
